The SCICONX Journal of Vaccine and Immunology (JVI) welcomes high‑quality manuscripts that contribute to the advancement of vaccine science and immunological research. Authors are encouraged to carefully review these instructions prior to submission to ensure compliance with the journal’s editorial, ethical, and technical requirements. Adherence to these guidelines facilitates an efficient peer‑review process and timely publication.

Manuscripts submitted to this journal must be original, unpublished, and not under consideration for publication elsewhere.

Scope Compatibility

Authors should ensure that their manuscript aligns with the journal’s aims and scope, focusing on immunology, vaccinology, immune‑based therapies, or related interdisciplinary research. Submissions outside the journal’s scope may be returned without peer review.

Article Types Accepted

The journal considers the following manuscript categories:

• Original Research Articles – Full‑length reports of novel experimental, clinical, or translational research.
• Review Articles – Comprehensive, critical analyses of current knowledge in specific areas of vaccine or immunology research.
• Systematic Reviews and Meta‑Analyses – Structured evidence syntheses conducted using recognized methodological standards.
• Short Communications – Concise reports of preliminary or innovative findings.
• Clinical Trial Reports – Studies reporting interventional or observational clinical investigations.
• Methodological and Technical Notes – Descriptions of new methods, protocols, or analytical approaches.
• Perspectives and Commentaries – Scholarly opinions on emerging trends, challenges, or policy‑relevant issues.
• Editorials and Special Issue Articles – By invitation or editorial decision.

Formatting Template (Click here to download).

Manuscript Preparation

General Formatting

• Manuscripts should be written in clear, professional English.
• Use a standard word‑processing format (DOC or DOCX preferred).
• Pages should be numbered consecutively.
• Line numbering is recommended to facilitate peer review.

Manuscript Structure

Title Page

The title page should include:

• Concise and informative manuscript title
• Full names of all authors
• Institutional affiliations
• Corresponding author’s email address
• ORCID iDs (where available)

Abstract

• A structured or unstructured abstract of 200–300 words, depending on article type.
• Abstracts should clearly summarize objectives, methods, key results, and conclusions.

Keywords

• Provide 4–6 relevant keywords to enhance discoverability.

Main Text

Original Research Articles should generally include:

• Introduction
• Materials and Methods
• Results
• Discussion
• Conclusions (optional but encouraged)

Other article types may follow alternative structures appropriate to their content.

Tables and Figures

• Tables and figures should be cited in the text in numerical order.
• Each table and figure must include a clear title and descriptive legend.
• Images should be of high resolution and submitted as separate files when required.

References

• References should be accurate, complete, and formatted consistently.
• The journal recommends using a numbered citation style.
• Authors are responsible for verifying the accuracy of all references.

Ethical Considerations

Human and Animal Research

• Studies involving human participants must include a statement confirming approval by an appropriate ethics committee and informed consent from participants.
• Animal studies must comply with institutional and international guidelines for animal welfare.

Clinical Trial Registration

• Clinical trials should be registered in a publicly accessible trial registry prior to participant enrolment.

Conflict of Interest

• All authors must disclose any financial or non‑financial conflicts of interest.

Authorship and Contributions

Authorship should be based on substantial contributions to study conception, design, data acquisition, analysis, or interpretation. All listed authors must approve the final manuscript and agree to its submission.

Plagiarism and Originality

The SCICONX Journal of Vaccine and Immunology maintains a strict policy against plagiarism, duplicate publication, and unethical research practices. All submissions may be screened using plagiarism detection software. Manuscripts found to violate originality standards may be rejected without review.

Use of Artificial Intelligence Tools

The use of artificial intelligence tools for language editing, data analysis, or figure preparation must be transparently disclosed. AI tools must not be listed as authors and cannot replace human scholarly responsibility.

Peer Review Process

All eligible manuscripts undergo a rigorous peer‑review process conducted by independent experts. Editorial decisions are based on scientific merit, originality, clarity, and relevance. Authors may be asked to revise their manuscripts in response to reviewer comments.

Submission Process

Manuscripts should be submitted through the journal’s official submission system or designated editorial email. Authors will receive confirmation upon successful submission and will be informed of the manuscript’s progress throughout the review process.

Publication Charges

As an open‑access journal, the journal may apply article processing charges (APCs) to support editorial and publishing services. Details regarding APCs, waivers, and discounts are provided on the journal’s website.

Copyright and Licensing

Authors retain copyright of their work while granting the journal the right to publish and distribute the article. Published articles are made available under an open‑access license, as specified by the journal.

For questions related to manuscript preparation or submission, authors are encouraged to contact the editorial office of the SCICONX Journal of Vaccine and Immunology through the official journal communication channels.